In smokers with COPD, LABA+LAMA is more effective than LABA+ICS in preventing exacerbations, regardless of blood eosinophil count.

The POET study investigated which LABD inhaler, LABA versus LAMA, to consider initiating first in patients with moderate-to-severe COPD and a history of exacerbations. [48] ...

Purpose of this review is providing a complete criticism of LAMA/LABA single inhaler treatment in COPD with particular mention to the most debated topics and future prospects in the field.

At the moment, the recommended treatment for COPD in Europe is an inhaled corticosteroid (ICS), a long-acting beta-agonist (LABA) and long-acting muscarinic antagonist (LAMA), or LABA/LAMA dual ...

Australians living with chronic obstructive pulmonary disease (COPD) are being exposed to greater health risks as the use of a critical diagnostic ...

Five-year View Many unmet needs in asthma and COPD management are still present. In asthma, strategies to improve control should be implemented, as well as the use of biomarkers in tailoring ...

Add the LAMA inhaler tiotropium and measure FEV 1 in a scheduled follow-up visit 2 weeks later. Tiotropium and a LABA have an additive effect on airway bronchodilatation. Discontinue LABA if there is ...

In the CRYSTAL study, patients with moderate COPD who were switched to Ultibro Breezhaler from their previous therapy (LABA+ICS * or LABA or LAMA) experienced superior improvements in lung ...

Inhaled corticosteroids, such as Arnuity Ellipta (fluticasone) or Pulmicort (budesonide) Combination meds with an ICS and LABA option to relax and open airways, like Advair (fluticasone with ...

Research shows that digital inhalers equipped with remote monitoring capabilities may aid in predicting and identifying ...

Digital inhalers may help predict the occurrence of acute exacerbations of chronic obstructive pulmonary disease (COPD) for ...